|
Completed
|
NCT05916989 -
Stimulant Use and Methylation in HIV
|
|
|
Recruiting
|
NCT04927143 -
Encouraging Abstinence Behavior in a Drug Epidemic
|
Phase 2 |
|
Completed
|
NCT03226223 -
Pharmacogenetics of Naltrexone for Stimulant Abuse
|
Phase 2 |
|
Completed
|
NCT02907853 -
Contingency Management for Meth in South Africa Methamphetamine Abuse in South Africa
|
N/A |
|
Recruiting
|
NCT04616625 -
Cardiovascular Effects of Prenatal Methamphetamine Exposure
|
|
|
Recruiting
|
NCT04061941 -
Change in Cognitive Function in Stimulant Users
|
|
|
Completed
|
NCT01967381 -
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
|
Early Phase 1 |
|
Terminated
|
NCT01019707 -
Safety Assessment of Atomoxetine With MA IV Administration
|
Phase 1 |
|
Completed
|
NCT01011829 -
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
|
Phase 2 |
|
Active, not recruiting
|
NCT04706624 -
Screen, Treat and Retain Meth-using People With Opioid Use Disorders at Methadone Clinics
|
N/A |
|
Recruiting
|
NCT05700994 -
Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
|
N/A |
|
Completed
|
NCT04109014 -
FASTLANE II: Reducing Sex, Drug, and Mental Health Risk
|
N/A |
|
Completed
|
NCT03336866 -
Study of Antibody for Methamphetamine Outpatient Therapy
|
Phase 1/Phase 2 |
|
Completed
|
NCT01822132 -
Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade
|
N/A |
|
Completed
|
NCT01062451 -
An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence
|
Phase 1 |
|
Not yet recruiting
|
NCT06233799 -
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
|
Phase 3 |
|
Recruiting
|
NCT05521854 -
Contingency Management for Drug Use: Does Age Matter?
|
N/A |
|
Completed
|
NCT01063205 -
NAC as a Potential Treatment for Methamphetamine Dependence
|
Phase 1 |
|
Not yet recruiting
|
NCT05334914 -
ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals
|
N/A |
|
Active, not recruiting
|
NCT05034874 -
Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200
|
Phase 2 |